Ahlem Clarence N. 4
4 · BIOVIE INC. · Filed Sep 28, 2021
Insider Transaction Report
Form 4
BIOVIE INC.BIVI
Ahlem Clarence N.
EVP Neuroscience Product Dev.
Transactions
- Award
Stock Option (right to buy)
2021-08-20+124,167→ 124,167 totalExercise: $7.74Exp: 2031-08-19→ COMMON STOCK (124,167 underlying)
Footnotes (1)
- [F1]This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.